The Oklahoma Medical Research Foundation (OMRF), located in the Oklahoma Health Center in Oklahoma City, Oklahoma, is an independent, nonprofit biomedical research institute. Established in 1946, OMRF is dedicated to understanding and developing more effective treatments for human disease. Andrew S. Weyrich, Ph.D. serves as president of OMRF, which employs more than 500 scientific and administrative staff members. OMRF's scientists, who include a member of the National Academy of Sciences, hold more than 700 U.S. and international patents and have spun off 11 biotech companies. Discoveries at OMRF led to Xigris, the first FDA-approved drug for the treatment of severe sepsis, and Ceprotin, a therapy for people suffering from a rare and life-threatening blood disorder known as protein C deficiency. Research at OMRF also identified the enzyme believed responsible for Alzheimer's disease and laid the groundwork for OncoVue, a breast cancer risk assessment test. More information...
According to PR-model, omrf.org is ranked 816,616th in multilingual Wikipedia, in particular this website is ranked 458,572nd in English Wikipedia.
The website is placed before flowejoin.com and after ditikiellada.gov.gr in the BestRef global ranking of the most important sources of Wikipedia.
